Arkolith/Insider Trading/EYPT/Form 4

Zaderej Karen L.

DirectorEyePoint Pharmaceuticals, Inc. (EYPT) · full profile →Form 4 · filed May 19, 2025
Net Buying
Open-Market Buys
$59K
Open-Market Sells
$0
Net Open-Market Flow
$59K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 19, 2025Buy(P)5K$5.99$30K37K
May 16, 2025Buy(P)5K$5.81$29K32K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-25-003997) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML